Literature DB >> 1725389

Plasma concentrations of endothelin-1 and endothelin-3 are altered differently in various pathophysiological conditions in humans.

T Miyauchi1, Y Sugishita, I Yamaguchi, R Ajisaka, T Tomizawa, M Onizuka, M Matsuda, I Kono, M Yanagisawa, K Goto.   

Abstract

Several studies have indicated that endothelin-1 (ET-1) and endothelin-3 (ET-3) are produced by different cells. Although ET-1 is produced by vascular endothelial cells, these cells do not produce ET-3. In the present study, we measured plasma concentrations of both ET-1 and ET-3 by sandwich-enzyme immunoassays which we developed recently in patients on chronic hemodialysis, age-matched normal subjects, patients with acute myocardial infarction, patients undergoing surgery, and healthy subjects before and after strenuous endurance exercise. Plasma levels of ET-1 and ET-3 were demonstrated to be altered differently in the above conditions in humans. Although the exact origin of circulating endothelins has yet to be elucidated, the different alterations of plasma levels suggest that both ET-1 and ET-3 may play different roles in physiological and/or pathophysiological responses to various conditions in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725389     DOI: 10.1097/00005344-199100177-00110

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  EndothelinB receptor-mediated contraction in human pulmonary resistance arteries.

Authors:  K M McCulloch; C C Docherty; I Morecroft; M R MacLean
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Endothelin-1, big endothelin-1, and nitric oxide in patients with chronic renal disease and hypertension.

Authors:  Ivanka Mikulić; József Petrik; Kresimir Galesić; Zeljko Romić; Ivana Cepelak; Monika Zeljko-Tomić
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Endothelin-1 in children with chronic renal failure.

Authors:  I Blazy; M Déchaux; M Charbit; D Brocart; J C Souberbielle; M F Gagnadoux; F Guillot; C Sachs
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.